Logo image of CRH

CRH PLC (CRH) Stock Fundamental Analysis

USA - NYSE:CRH - IE0001827041 - Common Stock

113.545 USD
+0.45 (+0.4%)
Last: 9/22/2025, 1:04:07 PM
Fundamental Rating

5

Taking everything into account, CRH scores 5 out of 10 in our fundamental rating. CRH was compared to 13 industry peers in the Construction Materials industry. CRH has an average financial health and profitability rating. CRH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRH had positive earnings in the past year.
CRH had a positive operating cash flow in the past year.
CRH had positive earnings in each of the past 5 years.
In the past 5 years CRH always reported a positive cash flow from operatings.
CRH Yearly Net Income VS EBIT VS OCF VS FCFCRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1.2 Ratios

CRH has a Return On Assets of 6.12%. This is in the better half of the industry: CRH outperforms 69.23% of its industry peers.
Looking at the Return On Equity, with a value of 14.79%, CRH is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
CRH has a better Return On Invested Capital (8.60%) than 61.54% of its industry peers.
CRH had an Average Return On Invested Capital over the past 3 years of 8.86%. This is in line with the industry average of 10.33%.
Industry RankSector Rank
ROA 6.12%
ROE 14.79%
ROIC 8.6%
ROA(3y)7.37%
ROA(5y)6.1%
ROE(3y)16.28%
ROE(5y)13.51%
ROIC(3y)8.86%
ROIC(5y)7.89%
CRH Yearly ROA, ROE, ROICCRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CRH has a worse Profit Margin (9.09%) than 69.23% of its industry peers.
In the last couple of years the Profit Margin of CRH has grown nicely.
With a Operating Margin value of 13.97%, CRH is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
CRH's Operating Margin has improved in the last couple of years.
The Gross Margin of CRH (35.99%) is better than 84.62% of its industry peers.
In the last couple of years the Gross Margin of CRH has grown nicely.
Industry RankSector Rank
OM 13.97%
PM (TTM) 9.09%
GM 35.99%
OM growth 3Y6.97%
OM growth 5Y6.8%
PM growth 3Y2.92%
PM growth 5Y9.98%
GM growth 3Y2%
GM growth 5Y1.6%
CRH Yearly Profit, Operating, Gross MarginsCRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

CRH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRH has less shares outstanding
Compared to 5 years ago, CRH has less shares outstanding
CRH has a worse debt/assets ratio than last year.
CRH Yearly Shares OutstandingCRH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CRH Yearly Total Debt VS Total AssetsCRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

CRH has an Altman-Z score of 3.28. This indicates that CRH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CRH (3.28) is better than 61.54% of its industry peers.
The Debt to FCF ratio of CRH is 7.23, which is on the high side as it means it would take CRH, 7.23 years of fcf income to pay off all of its debts.
CRH has a better Debt to FCF ratio (7.23) than 61.54% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that CRH is somewhat dependend on debt financing.
CRH's Debt to Equity ratio of 0.66 is on the low side compared to the rest of the industry. CRH is outperformed by 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 7.23
Altman-Z 3.28
ROIC/WACC1.23
WACC7.02%
CRH Yearly LT Debt VS Equity VS FCFCRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

CRH has a Current Ratio of 1.74. This is a normal value and indicates that CRH is financially healthy and should not expect problems in meeting its short term obligations.
CRH has a Current ratio (1.74) which is comparable to the rest of the industry.
CRH has a Quick Ratio of 1.16. This is a normal value and indicates that CRH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, CRH is in line with its industry, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.16
CRH Yearly Current Assets VS Current LiabilitesCRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.06% over the past year.
The Earnings Per Share has been growing by 12.30% on average over the past years. This is quite good.
The Revenue has been growing slightly by 1.78% in the past year.
Measured over the past years, CRH shows a small growth in Revenue. The Revenue has been growing by 4.80% on average per year.
EPS 1Y (TTM)16.06%
EPS 3Y14.85%
EPS 5Y12.3%
EPS Q2Q%5.95%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y6.79%
Revenue growth 5Y4.8%
Sales Q2Q%5.72%

3.2 Future

The Earnings Per Share is expected to grow by 9.09% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.07% on average over the next years.
EPS Next Y19.72%
EPS Next 2Y15.5%
EPS Next 3Y13.92%
EPS Next 5Y9.09%
Revenue Next Year4.85%
Revenue Next 2Y4.93%
Revenue Next 3Y5.16%
Revenue Next 5Y5.07%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CRH Yearly Revenue VS EstimatesCRH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
CRH Yearly EPS VS EstimatesCRH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.56, CRH is valued on the expensive side.
CRH's Price/Earnings is on the same level as the industry average.
CRH's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.38.
CRH is valuated rather expensively with a Price/Forward Earnings ratio of 17.88.
61.54% of the companies in the same industry are more expensive than CRH, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CRH to the average of the S&P500 Index (22.86), we can say CRH is valued slightly cheaper.
Industry RankSector Rank
PE 23.56
Fwd PE 17.88
CRH Price Earnings VS Forward Price EarningsCRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CRH's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRH indicates a somewhat cheap valuation: CRH is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 36.95
EV/EBITDA 13.22
CRH Per share dataCRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CRH has a very decent profitability rating, which may justify a higher PE ratio.
CRH's earnings are expected to grow with 13.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.19
PEG (5Y)1.91
EPS Next 2Y15.5%
EPS Next 3Y13.92%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.32%, CRH has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 4.31, CRH pays a better dividend. On top of this CRH pays more dividend than 84.62% of the companies listed in the same industry.
With a Dividend Yield of 1.32, CRH pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.32%

5.2 History

On average, the dividend of CRH grows each year by 25.12%, which is quite nice.
CRH has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)25.12%
Div Incr Years0
Div Non Decr Years0
CRH Yearly Dividends per shareCRH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

CRH pays out 29.51% of its income as dividend. This is a sustainable payout ratio.
CRH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.51%
EPS Next 2Y15.5%
EPS Next 3Y13.92%
CRH Yearly Income VS Free CF VS DividendCRH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
CRH Dividend Payout.CRH Dividend Payout, showing the Payout Ratio.CRH Dividend Payout.PayoutRetained Earnings

CRH PLC

NYSE:CRH (9/22/2025, 1:04:07 PM)

113.545

+0.45 (+0.4%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05
Inst Owners87.22%
Inst Owner Change-26.81%
Ins Owners0.15%
Ins Owner Change-4.03%
Market Cap80.81B
Analysts81.48
Price Target120.17 (5.83%)
Short Float %1.86%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield 1.32%
Yearly Dividend2.49
Dividend Growth(5Y)25.12%
DP29.51%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-22 2025-08-22 (0.37)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-31.96%
Min EPS beat(2)-64.29%
Max EPS beat(2)0.37%
EPS beat(4)1
Avg EPS beat(4)-25.47%
Min EPS beat(4)-64.29%
Max EPS beat(4)0.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-0.97%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)-0.33%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.15%
PT rev (3m)4.92%
EPS NQ rev (1m)-1.37%
EPS NQ rev (3m)-5.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 23.56
Fwd PE 17.88
P/S 2.22
P/FCF 36.95
P/OCF 16.37
P/B 3.62
P/tB 8.57
EV/EBITDA 13.22
EPS(TTM)4.82
EY4.25%
EPS(NY)6.35
Fwd EY5.59%
FCF(TTM)3.07
FCFY2.71%
OCF(TTM)6.93
OCFY6.11%
SpS51.07
BVpS31.4
TBVpS13.25
PEG (NY)1.19
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 6.12%
ROE 14.79%
ROCE 11.21%
ROIC 8.6%
ROICexc 9.19%
ROICexgc 13.19%
OM 13.97%
PM (TTM) 9.09%
GM 35.99%
FCFM 6.02%
ROA(3y)7.37%
ROA(5y)6.1%
ROE(3y)16.28%
ROE(5y)13.51%
ROIC(3y)8.86%
ROIC(5y)7.89%
ROICexc(3y)10.41%
ROICexc(5y)9.38%
ROICexgc(3y)15.61%
ROICexgc(5y)13.93%
ROCE(3y)11.55%
ROCE(5y)10.28%
ROICexcg growth 3Y9.81%
ROICexcg growth 5Y8.83%
ROICexc growth 3Y8.61%
ROICexc growth 5Y8.01%
OM growth 3Y6.97%
OM growth 5Y6.8%
PM growth 3Y2.92%
PM growth 5Y9.98%
GM growth 3Y2%
GM growth 5Y1.6%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 7.23
Debt/EBITDA 2.09
Cap/Depr 138.65%
Cap/Sales 7.56%
Interest Coverage 8.01
Cash Conversion 69.92%
Profit Quality 66.19%
Current Ratio 1.74
Quick Ratio 1.16
Altman-Z 3.28
F-Score6
WACC7.02%
ROIC/WACC1.23
Cap/Depr(3y)117.73%
Cap/Depr(5y)100.01%
Cap/Sales(3y)5.73%
Cap/Sales(5y)5.23%
Profit Quality(3y)75.96%
Profit Quality(5y)118.22%
High Growth Momentum
Growth
EPS 1Y (TTM)16.06%
EPS 3Y14.85%
EPS 5Y12.3%
EPS Q2Q%5.95%
EPS Next Y19.72%
EPS Next 2Y15.5%
EPS Next 3Y13.92%
EPS Next 5Y9.09%
Revenue 1Y (TTM)1.78%
Revenue growth 3Y6.79%
Revenue growth 5Y4.8%
Sales Q2Q%5.72%
Revenue Next Year4.85%
Revenue Next 2Y4.93%
Revenue Next 3Y5.16%
Revenue Next 5Y5.07%
EBIT growth 1Y9.69%
EBIT growth 3Y14.23%
EBIT growth 5Y11.93%
EBIT Next Year45.51%
EBIT Next 3Y19.01%
EBIT Next 5Y12.34%
FCF growth 1Y-10.66%
FCF growth 3Y-3.17%
FCF growth 5Y-0.78%
OCF growth 1Y18.15%
OCF growth 3Y5.82%
OCF growth 5Y5.15%